HER2‐positive BC subtypes are more likely to have X‐inactive‐specific transcript (XIST) downregulation, which promotes epithelial‐mesenchymal transition, motility, and migration of primary BC cells and especially increases the proclivity of circulating tumor cells (CTCs) to invade the brain.7 The gene discussed is ERBB2; the disease is breast cancer.